Kelderman Kim

Kelderman Kim is listed in filings as Chief Executive Officer at Bio-Techne Corp. This profile follows SEC Form 4 activity through May 7, 2026, including sale activity. Recent filings connect the profile to Bio-Techne Corp (TECH) and CONMED Corporation (CNMD). The current snapshot covers public activity from Aug 2, 2024 to May 7, 2026. Reported amounts are shown as $1.4M to $540.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.